Covered recipient · General Payments record
GINA M MORAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$410.70
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $220.98 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $37.73 | 2 |
| Acerta Pharma LLC | $32.61 | 2 |
| Xeris Pharmaceuticals, Inc. | $24.46 | 1 |
| Astellas Pharma US Inc | $23.35 | 1 |
| Janssen Pharmaceuticals, Inc | $23.14 | 1 |
| Novo Nordisk AS | $18.12 | 1 |
| Exact Sciences Corporation | $17.36 | 1 |
| DEXCOM, INC. | $15.50 | 1 |
| Lilly USA, LLC | $14.78 | 1 |
| Lundbeck LLC | $13.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $23.35 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139279054 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.16 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104368331 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.45 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104503126 | CMS |
| Dexcom, Inc. | $15.50 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153301809 | CMS |
| Exact Sciences Corporation | $17.36 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114796188 | CMS |
| Janssen Pharmaceuticals, Inc | $23.14 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077999312 | CMS |
| Lilly USA, LLC | $14.78 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987872 | CMS |
| Lundbeck LLC | $13.93 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145948032 | CMS |
| Novo Nordisk Inc | $18.12 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096686494 | CMS |
| PFIZER INC. | $17.77 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131167797 | CMS |
| PFIZER INC. | $19.96 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131472682 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.46 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144595558 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.